Autoimmune hepatitis in pediatrics, a review by the Working Group of the Latin American Society for Pediatric Gastroenterology, Hepatology, and Nutrition

Ramonet M.; Ramirez-Rodriguez N.; Chávez F.Á.; Arregui M.C.; Boldrini G.; Osorio V.B.; Cuarterolo M.; Godoy M.; Monroy F.A.M.; Oropeza G.; Carusi R.P.; Rodríguez D.P.; Reynoso-Zarzosa F.A.; Ciocca M. · Archivos Argentinos de Pediatria (2022) · DOI: 10.5546/aap.2022.eng.281

Resumen

Autoimmune hepatitis (AIH) is a chronic inflammatoryconditionofthelivercharacterized by a complex interaction among genetic factors, immune response to antigens present in hepatocytes, and immune regulation alterations. Its distribution is global and there is a female predominance. AIH is divided into 2 groups, depending on the type of serum autoantibodies detected. The most common presentation is acute hepatitis (40%), with nonspecific symptoms, high aminotransferase levels,andhypergammaglobulinemia.Standard treatment consists of the administration of immunosuppressive drugs. It is a complex condition, often difficult to diagnose. If not managed adequately, the 5-year mortality rate may reach 75%.